News & Announcements
Fox Chase Cancer Center Leader Tours China with Mayor Nutter
Fox Chase Cancer Center will be sharing its oncologic expertise with peers at Tianjin Medical University Cancer Institute and Hospital in Tianjin, China, thanks to an agreement signed in the Chinese port city on December 3.
Kurt Schwinghammer, PhD, Vice President of Research & Development Alliances at Fox Chase Cancer Center and head of Fox Chase International, was a member of a contingent of Philadelphia leaders in medicine, education, law, and the arts traveling with Mayor Michael Nutter to Tianjin — which, since 1980, has been a Sister City of Philadelphia.
Mayor Nutter's trip focused on encouraging international investment in Philadelphia and strengthening relationships between important local institutions and their counterparts in China. The trip also took the group about 70 miles northwest of Tianjin to Beijing, where Mayor Nutter, current president of the U.S. Conference of Mayors, spoke on urban sustainability.
According to Dr. Schwinghammer, urban sustainability - the concept central to the Mayor's activities in China - is linked to Fox Chase's mission. "Cancer is now the leading cause of death in China, with lung cancer being at the top of the list. It is likely that there is a relationship between long-term exposure to air pollution and cancer," he explained.
The partnership forged in Tianjin is not the first of its kind for Fox Chase. Through Fox Chase International, the Center seeks to align the skills and resources of cancer research, diagnosis and treatment available at Fox Chase with the extraordinary growth of cancer treatment and diagnostic requirements in China and other nations. So far, Fox Chase has formed relationships with institutions in six cities in China and India.
Date Published: Thursday, December 27, 2012
back | view all news
Jennifer Gordon, PhD, Appointed Assistant Dean for Research at Temple University School of Medicine
Jennifer Gordon, PhD, has been appointed Assistant Dean for Research at Temple University School of Medicine.
read more »
Temple First in Philadelphia Region to Offer New Treatment for Peripheral Artery Disease
Treatment utilizes first FDA-approved drug-coated balloon.
read more »
Transforming Temple Health’s Clinical Research Infrastructure
Cinical researchers at Temple Health will now benefit from the new Temple Clinical Research Institute – an infrastructure of expertise and resources to enhance and accelerate multidisciplinary clinical research of the highest quality.
read more »